Metastatic placental site trophoblastic tumor.
A patient with metastatic placental site trophoblastic tumor is presented. Her treatment included several aggressive chemotherapeutic regimens. In this patient, the clinical course and assays of beta-hCG (beta fragment of human chorionic gonadotropin) correlated with her response to these treatments.
Alvero
R
R
Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC 20307.
Remmenga
S
S
O'Connor
D
D
Barnhill
D
D
Park
R
R
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010922:Placenta Diseases / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011247:Pregnancy; D013534:Survival; D014057:Tomography, X-Ray Computed; D014328:Trophoblastic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D003520:Cyclophosphamide; D008727:Methotrexate